Brian Dausch, CFA

Brian Dausch, CFA, Portfolio Specialist

  • B.S., University of Delaware

Brian Dausch is a portfolio specialist in the U.S. Equity Division. He is a member of the Global Natural Resources Equity, US Mid-Cap Growth Equity, US Small-Cap Growth Equity, QM US Small-Cap Growth Equity, and Health Sciences Equity Strategy teams, working closely with institutional clients, consultants, and prospects. He is a vice president of T. Rowe Price Group, Inc.  

Brian’s investment experience began in 1997, and he has been with T. Rowe Price since 1998, beginning in the U.S. Equity Division as an associate investment analyst covering biotechnology and pharmaceutical companies. Prior to his current role, Brian managed the U.S. Equity Portfolio Analysis Group.

Brian earned a B.S. in business administration, with a concentration in finance, from the University of Delaware. He also has earned the Chartered Financial Analyst® designation.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

  • Years at T. Rowe Price22
  • Years investment experience23
Health Sciences Fund
Portfolio Specialist
Health Sciences Fund - I Class
Portfolio Specialist
Health Sciences Portfolio
Portfolio Specialist
Health Sciences Portfolio II
Portfolio Specialist
Mid-Cap Growth Fund
Portfolio Specialist
Mid-Cap Growth Fund - I Class
Portfolio Specialist
Mid-Cap Growth Fund - R Class
Portfolio Specialist
Mid-Cap Growth Portfolio
Portfolio Specialist
Mid-Cap Growth Portfolio II
Portfolio Specialist
New Era Fund
Portfolio Specialist
New Era Fund - I Class
Portfolio Specialist
New Horizons Fund
Portfolio Specialist
New Horizons Fund - I Class
Portfolio Specialist
Real Assets Fund
Portfolio Specialist
Real Assets Fund - I Class
Portfolio Specialist
Dismiss
Tap to dismiss